Pfizer faces renewed bid for Xalkori royalties as appeals panel revives NYU lawsuit esagonowsky Thu, 05/04/2017 – 10:16 More: Pfizer faces renewed bid for Xalkori royalties as appeals panel revives NYU lawsuit Source: fierce
read moreDrug pricing woes ease a bit, wholesaler AmerisourceBergen’s Q2 indicates epalmer Thu, 05/04/2017 – 09:59 More: Drug pricing woes ease a bit, wholesaler AmerisourceBergen's Q2 indicates Source: fierce
read moreAstraZeneca has hooked up with US group Pieris Pharmaceuticals to develop novel inhaled medicines for respiratory diseases in a deal potentially worth $2.1 billion. More: AZ and Pieris link in .1bn respiratory deal Source: News
read moreNovartis has exercised an option giving it global development and commercialisation rights to an experimental drug being developed by US biotech Conatus for nonalcoholic steatohepatitis (NASH), a progressive form of non-alcoholic fatty liver disease. More: Novartis scoops up rights to
read moreResearchers have developed a blood test that could better tailor the treatment of patients with prostate cancer. More: £50 blood test could predict prostate cancer drug response Source: News
read morePharmacy Times More: FDA approves stimulation therapy device for episodic cluster headache Source: MDlinx
read more© 1994 - 2026 B.M. Pharmaceuticals